Kemal Malik's most recent trade in Cartesian Therapeutics Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Kemal Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Kemal Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 8,533 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Kemal Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 7,600 | 7,600 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Kemal Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 5,933 | 5,933 (0%) | 0% | 0 | Common Stock |